{
  "id": 5376,
  "text": "Gynecol Oncol 2009;114:528-535.Available at: http://www.ncbi.nlm.nih.gov/pubmed/19560188.195.Gee MS, Atri M, Bandos AI, et al.Identification of Distant Metastatic Disease in Uterine Cervical and Endometrial Cancers with FDG PET/CT: Analysis from the ACRIN 6671/GOG 0233 Multicenter Trial.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Gynecol Oncol 2009;114:528-535.Available at: http://www.ncbi.nlm.nih.gov/pubmed/19560188.195.Gee MS, Atri M, Bandos AI, et al.Identification of Distant Metastatic Disease in Uterine Cervical and Endometrial Cancers with FDG PET/CT: Analysis from the ACRIN 6671/GOG 0233 Multicenter Trial.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "FDG PET/CT技术是一种有效的高分辨率影像技术，可以用于识别宫颈癌患者的远处转移病变。当患者疑似存在远处转移或常规影像如CT、MRI未能明确诊断转移病变时，使用FDG PET/CT可能提供额外的信息。此外，对于临床检查结果和其他影像结果存在不一致的情况下，FDG PET/CT能够帮助确认病变是否为转移，有助于制定更精确的治疗计划。这种技术利用FDG的高摄取特性在肿瘤细胞中积聚，从而在影像上显示出可能的远处转移病灶。通常针对晚期宫颈癌患者或治疗后需要评估病情发展时，FDG PET/CT显得尤为重要。",
  "query": "在什么情况下可以通过FDG PET/CT技术有效识别宫颈癌患者的远处转移病变？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在什么情况下可以通过FDG PET/CT技术有效识别宫颈癌患者的远处转移病变？\n\n<reference text>: Gynecol Oncol 2009;114:528-535.Available at: http://www.ncbi.nlm.nih.gov/pubmed/19560188.195.Gee MS, Atri M, Bandos AI, et al.Identification of Distant Metastatic Disease in Uterine Cervical and Endometrial Cancers with FDG PET/CT: Analysis from the ACRIN 6671/GOG 0233 Multicenter Trial.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "FDG PET/CT技术是一种有效的高分辨率影像技术，可以用于识别宫颈癌患者的远处转移病变。当患者疑似存在远处转移或常规影像如CT、MRI未能明确诊断转移病变时，使用FDG PET/CT可能提供额外的信息。此外，对于临床检查结果和其他影像结果存在不一致的情况下，FDG PET/CT能够帮助确认病变是否为转移，有助于制定更精确的治疗计划。这种技术利用FDG的高摄取特性在肿瘤细胞中积聚，从而在影像上显示出可能的远处转移病灶。通常针对晚期宫颈癌患者或治疗后需要评估病情发展时，FDG PET/CT显得尤为重要。"
}